Collectively, our in vivo findings demonstrate that S100A8 and S100A9 practically regulate the apoptotic mechanisms of eosinophilic abnormalities such as CEL and HES. The gene discussed is S100A9; the disease is Chronic Eosinophilic Leukemia, Not Otherwise Specified.